Literature DB >> 20303880

Mechanisms underlying inflammation in neurodegeneration.

Christopher K Glass1, Kaoru Saijo, Beate Winner, Maria Carolina Marchetto, Fred H Gage.   

Abstract

Inflammation is associated with many neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis. In this Review, we discuss inducers, sensors, transducers, and effectors of neuroinflammation that contribute to neuronal dysfunction and death. Although inducers of inflammation may be generated in a disease-specific manner, there is evidence for a remarkable convergence in the mechanisms responsible for the sensing, transduction, and amplification of inflammatory processes that result in the production of neurotoxic mediators. A major unanswered question is whether pharmacological inhibition of inflammation pathways will be able to safely reverse or slow the course of disease. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20303880      PMCID: PMC2873093          DOI: 10.1016/j.cell.2010.02.016

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  147 in total

1.  Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice.

Authors:  A M Clement; M D Nguyen; E A Roberts; M L Garcia; S Boillée; M Rule; A P McMahon; W Doucette; D Siwek; R J Ferrante; R H Brown; J-P Julien; L S B Goldstein; D W Cleveland
Journal:  Science       Date:  2003-10-03       Impact factor: 47.728

2.  Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.

Authors:  Paul S Aisen; Kimberly A Schafer; Michael Grundman; Eric Pfeiffer; Mary Sano; Kenneth L Davis; Martin R Farlow; Shelia Jin; Ronald G Thomas; Leon J Thal
Journal:  JAMA       Date:  2003-06-04       Impact factor: 56.272

3.  A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS.

Authors:  Paul H Gordon; Ying-Kuen Cheung; Bruce Levin; Howard Andrews; Carolyn Doorish; Robert B Macarthur; Jacqueline Montes; Kate Bednarz; Julaine Florence; Julie Rowin; Kevin Boylan; Tahseen Mozaffar; Rup Tandan; Hiroshi Mitsumoto; Elizabeth A Kelvin; John Chapin; Richard Bedlack; Michael Rivner; Leo F McCluskey; Alan Pestronk; Michael Graves; Eric J Sorenson; Richard J Barohn; Jerry M Belsh; Jau-Shin Lou; Todd Levine; David Saperstein; Robert G Miller; Stephen N Scelsa
Journal:  Amyotroph Lateral Scler       Date:  2008-08

4.  The NALP3 inflammasome is involved in the innate immune response to amyloid-beta.

Authors:  Annett Halle; Veit Hornung; Gabor C Petzold; Cameron R Stewart; Brian G Monks; Thomas Reinheckel; Katherine A Fitzgerald; Eicke Latz; Kathryn J Moore; Douglas T Golenbock
Journal:  Nat Immunol       Date:  2008-07-11       Impact factor: 25.606

Review 5.  Fat and beyond: the diverse biology of PPARgamma.

Authors:  Peter Tontonoz; Bruce M Spiegelman
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

Review 6.  Multiple sclerosis: an immune or neurodegenerative disorder?

Authors:  Bruce D Trapp; Klaus-Armin Nave
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

7.  Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription.

Authors:  Xiangting Wang; Shigeki Arai; Xiaoyuan Song; Donna Reichart; Kun Du; Gabriel Pascual; Paul Tempst; Michael G Rosenfeld; Christopher K Glass; Riki Kurokawa
Journal:  Nature       Date:  2008-05-28       Impact factor: 49.962

Review 8.  Interactions between APP secretases and inflammatory mediators.

Authors:  Magdalena Sastre; Jochen Walter; Steve M Gentleman
Journal:  J Neuroinflammation       Date:  2008-06-18       Impact factor: 8.322

9.  Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.

Authors:  Rebecca Banerjee; R Lee Mosley; Ashley D Reynolds; Alok Dhar; Vernice Jackson-Lewis; Paul H Gordon; Serge Przedborski; Howard E Gendelman
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

10.  Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease.

Authors:  Jing-Ji Jin; Hong-Duck Kim; J Adam Maxwell; Ling Li; Ken-Ichiro Fukuchi
Journal:  J Neuroinflammation       Date:  2008-05-29       Impact factor: 8.322

View more
  1197 in total

1.  Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson's disease.

Authors:  Souvarish Sarkar; Hai M Nguyen; Emir Malovic; Jie Luo; Monica Langley; Bharathi N Palanisamy; Neeraj Singh; Sireesha Manne; Matthew Neal; Michelle Gabrielle; Ahmed Abdalla; Poojya Anantharam; Dharmin Rokad; Nikhil Panicker; Vikrant Singh; Muhammet Ay; Adhithiya Charli; Dilshan Harischandra; Lee-Way Jin; Huajun Jin; Srikant Rangaraju; Vellareddy Anantharam; Heike Wulff; Anumantha G Kanthasamy
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

2.  Cynandione A attenuates lipopolysaccharide-induced production of inflammatory mediators via MAPK inhibition and NF-κB inactivation in RAW264.7 macrophages and protects mice against endotoxin shock.

Authors:  Sung Hwan Kim; Tae Hoon Lee; Sang Min Lee; Ji Hae Park; Keun Hyung Park; Mira Jung; Hana Jung; Mohamed Antar Aziz Mohamed; Nam-In Baek; In Sik Chung; Jiyoung Kim
Journal:  Exp Biol Med (Maywood)       Date:  2014-10-30

Review 3.  Exploiting oxidative microenvironments in the body as triggers for drug delivery systems.

Authors:  Shivanjali Joshi-Barr; Caroline de Gracia Lux; Enas Mahmoud; Adah Almutairi
Journal:  Antioxid Redox Signal       Date:  2014-04-15       Impact factor: 8.401

4.  TFP5, a peptide derived from p35, a Cdk5 neuronal activator, rescues cortical neurons from glucose toxicity.

Authors:  B K Binukumar; Ya-Li Zheng; Varsha Shukla; Niranjana D Amin; Philip Grant; Harish C Pant
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

5.  Steering the Clinical Translation of Delivery Systems for Drugs and Health Products.

Authors:  Rosario Pignatello; Pietro Matricardi
Journal:  Pharmaceutics       Date:  2020-04-13       Impact factor: 6.321

Review 6.  Combination therapies: The next logical Step for the treatment of synucleinopathies?

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Mov Disord       Date:  2015-09-21       Impact factor: 10.338

7.  Tinospora cordifolia Suppresses Neuroinflammation in Parkinsonian Mouse Model.

Authors:  Hareram Birla; Sachchida Nand Rai; Saumitra Sen Singh; Walia Zahra; Arun Rawat; Neeraj Tiwari; Rakesh K Singh; Abhishek Pathak; Surya Pratap Singh
Journal:  Neuromolecular Med       Date:  2019-01-14       Impact factor: 3.843

Review 8.  Multitasking Microglia and Alzheimer's Disease: Diversity, Tools and Therapeutic Targets.

Authors:  Alexandra Grubman; Katja M Kanninen; Tarja Malm
Journal:  J Mol Neurosci       Date:  2016-09-22       Impact factor: 3.444

9.  Neuroprotective effect of diclofenac on chlorpromazine induced catalepsy in rats.

Authors:  Sadaf Naeem; Rahila Najam; Saira Saeed Khan; Talat Mirza; Bushra Sikandar
Journal:  Metab Brain Dis       Date:  2019-05-04       Impact factor: 3.584

10.  Diazoxide pretreatment prevents Aβ1-42 induced oxidative stress in cholinergic neurons via alleviating NOX2 expression.

Authors:  Qingxi Fu; Naiyong Gao; Jixu Yu; Guozhao Ma; Yifeng Du; Fumin Wang; Quanping Su; Fengyuan Che
Journal:  Neurochem Res       Date:  2014-04-27       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.